Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M48.8Revenue $M0.3Net Margin (%)0Z-Score-11.6
Enterprise Value $M33.4EPS $-0.3Operating Margin %0F-Score2
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yY
Price/Book3.710-y EBITDA Growth Rate %-2.0Quick Ratio5.3Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %1.4Current Ratio5.3Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-84.6Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-104.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M89.6ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with ONCY

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ONCYJean-Marie Eveillard 2014-09-30 Sold Out $0.563 - $1.66
($1.28)
$ 0.55-57%Sold Out0
ONCYJean-Marie Eveillard 2014-06-30 Reduce$1.23 - $1.99
($1.43)
$ 0.55-62%Reduce -55.85%188,600
ONCYJean-Marie Eveillard 2013-03-31 Buy $2.99 - $4.67
($3.6)
$ 0.55-85%New holding, 450000 sh.450,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ONCY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ONCY Jean-Marie Eveillard 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


ONCY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Dillahunty, Mary AnnSenior Officer 2014-11-13Sell1,201$0.61-9.84view
Hohol, Linda Margaret OwerriDirector 2014-10-20Buy10,000$0.56-1.79view
Dinning, James FrancisDirector 2014-10-03Buy10,000$0.61-9.84view
Thompson, BradleyDirector, Senior Officer 2014-10-03Buy10,000$0.61-9.84view
Levy, EdwinDirector 2014-10-03Buy16,000$0.62-11.29view
Dinning, James FrancisDirector 2014-10-02Buy20,000$0.6-8.33view
Hohol, Linda Margaret OwerriDirector 2014-08-12Buy6,800$1.51-63.58view
Dinning, James FrancisDirector 2014-07-04Buy15,000$1.45-62.07view
Levy, EdwinDirector 2014-01-03Buy5,900$1.72-68.02view
Dinning, James FrancisDirector 2013-12-13Buy5,000$1.62-66.05view

Press Releases about ONCY :

    Quarterly/Annual Reports about ONCY:

      News about ONCY:

      Articles On GuruFocus.com
      No related article found.

      More From Other Websites
      Nasdaq stocks posting largest volume increases Dec 18 2014
      Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® and Checkpoint Inhibitor Combination... Dec 04 2014
      Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® and Checkpoint Inhibitor Combination... Dec 04 2014
      Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® and Checkpoint Inhibitor Combination... Dec 04 2014
      Oncolytics Files for Orphan Drug Designation for Reolysin Dec 03 2014
      Oncolytics Biotech® Inc. Announces Filing for Orphan Drug Designation with the U.S. FDA for... Dec 02 2014
      Oncolytics Biotech® Inc. Announces Filing for Orphan Drug Designation with the U.S. FDA for... Dec 02 2014
      Oncolytics Biotech® Inc. Announces Filing for Orphan Drug Designation with the U.S. FDA for... Dec 02 2014
      Media Advisory - Oncolytics Biotech® Inc. to Participate in the Stifel 2014 Healthcare Conference Nov 18 2014
      Media Advisory - Oncolytics Biotech® Inc. to Participate in the Stifel 2014 Healthcare Conference Nov 18 2014
      Media Advisory - Oncolytics Biotech® Inc. to Participate in the Stifel 2014 Healthcare Conference Nov 18 2014
      Oncolytics Biotech® Inc. Announces Third Quarter 2014 Results Nov 06 2014
      Oncolytics Biotech® Inc. Announces Third Quarter 2014 Results Nov 06 2014
      Oncolytics Biotech® Inc. Announces Receipt of Nasdaq Notice of Deficiency Nov 04 2014
      Oncolytics Biotech® Inc. Announces Receipt of Nasdaq Notice of Deficiency Nov 04 2014
      Oncolytics Biotech® Inc. Announces Receipt of Nasdaq Notice of Deficiency Nov 04 2014
      Geron Corporation (GERN) Looks Strong: Stock Up 25.6% Nov 04 2014
      Oncolytics Biotech (ONCY) Looks Strong: Stock Up 21.9% Nov 03 2014
      Oncolytics Biotech (ONCY) Looks Good: Stock Soars 26% Oct 30 2014
      Novavax (NVAX) in Focus: Stock Rises 13% Oct 28 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK